[1]
|
Carnosic Acid, Tangeretin, and Ginkgolide-B Anti-neoplastic Cytotoxicity in Dual Combination with Dexamethasone-[anti-EGFR] in Pulmonary Adenocarcinoma (A549)
Anti-Cancer Agents in Medicinal Chemistry,
2019
DOI:10.2174/1871520619666181204100226
|
|
|
[2]
|
Anti-neoplastic cytotoxicity by complementary simultaneous selective “targeted” delivery for pulmonary adenocarcinoma: fludarabine-(5′-phosphoramidate)-[anti-IGF-1R] in dual-combination with dexamethasone-(C21-phosphoramidate)-[anti-EGFR]
Journal of Pharmaceutical Investigation,
2018
DOI:10.1007/s40005-018-0401-9
|
|
|
[3]
|
Gemcitabine‐(5′‐phosphoramidate)‐[anti‐IGF‐1R]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency in populations of pulmonary adenocarcinoma (A549)
Chemical Biology & Drug Design,
2017
DOI:10.1111/cbdd.12845
|
|
|
[4]
|
Gemcitabine-(5′-phosphoramidate)-[anti-IGF-1R]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency in populations of pulmonary adenocarcinoma (A549)
Chemical Biology & Drug Design,
2017
DOI:10.1111/cbdd.12845
|
|
|
[5]
|
Simultaneous Dual Selective Targeted Delivery of Two Covalent Gemcitabine Immunochemotherapeutics and Complementary Anti-Neoplastic Potency of [Se]-Methylselenocysteine
Journal of Cancer Therapy,
2015
DOI:10.4236/jct.2015.61009
|
|
|
[6]
|
Synthesis of a Covalent Epirubicin-(C3-amide)-Anti-HER2/neuImmunochemotherapeutic Utilizing a UV-Photoactivated Anthracycline Intermediate
Cancer Biotherapy & Radiopharmaceuticals,
2012
DOI:10.1089/cbr.2011.1097
|
|
|
[7]
|
Synthesis of Gemcitabine-(C4-amide)-[anti-HER2/neu] Utilizing a UV-Photoactivated Gemcitabine Intermediate: Cytotoxic Anti-Neoplastic Activity against Chemotherapeutic-Resistant Mammary Adenocarcinoma SKBr-3
Journal of Cancer Therapy,
2012
DOI:10.4236/jct.2012.325089
|
|
|